MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q3
hinzugefügt 23.12.2023
Aerie Pharmaceuticals ROA 2011-2026 | AERI
ROA Jährlich Aerie Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -17.34 | -45.54 | -44.1 | -81.59 | -49.99 | -39.9 | -46.73 | -29.88 | -44.21 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -17.34 | -81.59 | -44.36 |
ROA Vierteljährlich Aerie Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -21.24 | -32.53 | -36.67 | -42.52 | -33.73 | -45.21 | -44.74 | -46.36 | -46.71 | -47.4 | -47.51 | -45.42 | -44.1 | -49.98 | -69.02 | -77.91 | -81.59 | -83.7 | -64.89 | -55.38 | -49.99 | -41.64 | -40.08 | -39.64 | -39.9 | -40.9 | -42.59 | -45.04 | -46.73 | -44.25 | -41.12 | -36.65 | -29.96 | -43.06 | -50.15 | -51.8 | -53.03 | -350.18 | -446.51 | -437.53 | -432.15 | -111.59 | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -21.24 | -446.51 | -84.07 |
ROA anderer Aktien in der Arzneimittelhersteller
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-48.08 | - | 7.5 % | $ 6.35 M |  USA |
 |
Alimera Sciences
ALIM
|
-13.11 | - | - | $ 142 M | USA |
 |
Agile Therapeutics
AGRX
|
-141.05 | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-242.23 | - | 0.86 % | $ 117 M | USA |
 |
Aurora Cannabis
ACB
|
-26.69 | $ 3.3 | -0.3 % | $ 86.3 M |  Canada |
 |
China Pharma Holdings
CPHI
|
-31.81 | $ 0.63 | - | $ 11 M |  China |
 |
Catalent
CTLT
|
-10.69 | - | - | $ 11.5 B | USA |
 |
Athenex
ATNX
|
-50.69 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-29.73 | - | - | $ 2.06 B |  France |
 |
Cronos Group
CRON
|
-3.8 | $ 2.55 | 1.19 % | $ 1.32 B | Canada |
 |
DURECT Corporation
DRRX
|
-61.13 | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
-41.71 | $ 8.04 | -0.12 % | $ 412 M | USA |
 |
Endo International plc
ENDP
|
-47.69 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-110.24 | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-34.9 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-8.75 | - | 2.45 % | $ 38.1 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
-2.52 | $ 3.18 | 4.1 % | $ 44.7 M | USA |
 |
Pacira BioSciences
PCRX
|
-6.41 | $ 22.82 | 0.75 % | $ 1.06 B | USA |
 |
Bausch Health Companies
BHC
|
-2.16 | $ 4.97 | -2.55 % | $ 1.81 B | Canada |
 |
Harrow Health
HROW
|
-1.29 | $ 35.03 | 3.03 % | $ 1.29 B | USA |
 |
OptiNose
OPTN
|
-32.94 | - | - | $ 1.08 B | USA |
 |
Evolus
EOLS
|
-22.86 | $ 4.43 | -5.45 % | $ 286 M | USA |
 |
Rockwell Medical
RMTI
|
-16.18 | $ 1.04 | 1.96 % | $ 24.3 M | USA |
 |
SCYNEXIS
SCYX
|
-14.58 | $ 0.87 | -0.29 % | $ 43.4 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
8.78 | - | -39.89 % | $ 27.7 M | USA |
 |
Solid Biosciences
SLDB
|
-74.97 | $ 6.69 | -6.3 % | $ 585 M | USA |
 |
Sundial Growers
SNDL
|
-16.12 | $ 1.36 | -0.37 % | $ 3.37 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-25.25 | $ 2.34 | -8.24 % | $ 2.9 M | USA |
 |
Relmada Therapeutics
RLMD
|
-61.05 | $ 6.01 | 2.56 % | $ 237 M | USA |
 |
OrganiGram Holdings
OGI
|
-23.59 | $ 1.36 | 0.01 % | $ 402 M | Canada |
 |
PetIQ
PETQ
|
0.25 | - | 1.64 % | $ 400 M | USA |
 |
Tilray
TLRY
|
-33.73 | $ 6.57 | 1.86 % | $ 4.06 B | Canada |
 |
PLx Pharma
PLXP
|
-60.18 | - | -27.8 % | $ 2.56 M | USA |
 |
ProPhase Labs
PRPH
|
21.06 | - | - | $ 5.07 M | USA |
 |
Jupiter Wellness
JUPW
|
-673.3 | - | - | $ 33.6 M | USA |
 |
TherapeuticsMD
TXMD
|
-23.73 | $ 2.28 | -1.2 % | $ 23.8 M | USA |
 |
Radius Health
RDUS
|
-38.66 | - | - | $ 1.42 B | USA |
 |
Veru
VERU
|
-62.57 | $ 2.28 | -0.87 % | $ 308 M | USA |
 |
Viatris
VTRS
|
4.16 | $ 13.43 | 1.02 % | $ 16.1 B | USA |
 |
Lannett Company
LCI
|
-47.81 | - | 1.15 % | $ 7.11 M | USA |
 |
cbdMD
YCBD
|
-1.44 | $ 0.78 | 1.3 % | $ 3.36 M | USA |
 |
Organogenesis Holdings
ORGO
|
0.17 | $ 2.43 | -1.62 % | $ 320 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
6.13 | - | - | $ 193 M | Canada |
 |
Perrigo Company plc
PRGO
|
-16.7 | $ 9.65 | 0.89 % | $ 1.34 B | USA |
 |
Canopy Growth Corporation
CGC
|
-65.18 | $ 0.94 | -2.32 % | $ 101 M | Canada |
 |
Assertio Holdings
ASRT
|
-11.38 | $ 15.95 | 13.93 % | $ 102 M | USA |
 |
Recro Pharma
REPH
|
-8.65 | - | -4.76 % | $ 65.3 M | USA |
 |
Tricida
TCDA
|
-104.78 | - | - | $ 3.25 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-63.1 | - | - | $ 55.5 M | USA |